{
  "CitationSubset": [
    "OM"
  ],
  "KeywordList": [
    [
      "AUTONOMIC NERVOUS SYSTEM/diseases",
      "BARBITURATES/therapeutic use",
      "DEPRESSION/therapy",
      "PHENYLETHYLAMINES/therapeutic use"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [
    "5527:14630:53:58:135:353"
  ],
  "InvestigatorList": [],
  "PMID": "13202974",
  "DateCompleted": {
    "Year": "2003",
    "Month": "05",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0025-8458",
      "JournalIssue": {
        "Volume": "49",
        "Issue": "31",
        "PubDate": {
          "Year": "1954",
          "Month": "Jul",
          "Day": "30"
        }
      },
      "Title": "Medizinische Klinik",
      "ISOAbbreviation": "Med Klin"
    },
    "ArticleTitle": "[Clinical experience with a new combination drug (metrotonin) in the treatment of depressions and autonomic dystonia].",
    "Pagination": {
      "StartPage": "1218",
      "EndPage": "1221",
      "MedlinePgn": "1218-21"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "RAUSCHELBACH",
        "ForeName": "H H",
        "Initials": "HH"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "Klinische Erfahrungen mit einem neuen Kombinationspr\u00e4parat (Metrotonin) zur Behandlung von Verstimmungszust\u00e4nden und vegetativen Dysregulationen."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Med Klin",
    "NlmUniqueID": "0376637",
    "ISSNLinking": "0025-8458"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Barbiturates"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Phenethylamines"
    },
    {
      "RegistryNumber": "44RAL3456C",
      "NameOfSubstance": "Methamphetamine"
    },
    {
      "RegistryNumber": "IYE3F3MHCU",
      "NameOfSubstance": "dimethylamphetamine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Autonomic Nervous System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Autonomic Nervous System Diseases"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Barbiturates"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dystonia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Methamphetamine"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Phenethylamines"
    }
  ]
}